Locations
Company type
Result types
Industries
Employees
Founding year
The B2B platform for the best purchasing descision. Identify and compare relevant B2B manufacturers, suppliers and retailers
Close
Filter
Result configuration
Continents
Select continent
Locations
Result types
Company type
Select company type
Industries
Select industry
Company status
Select company status preset
Number of employees
Min.
Max.
Founding year
EdiTy Therapeutics
Ness Ziona, Israel
B
1-10 Employees
2020
Key takeaway
Edity Therapeutics is focused on utilizing immune cells to deliver therapeutic proteins directly to the cytoplasm of diseased cells, which has significant implications for CAR-T cell therapy and other immunotherapeutic approaches. Their innovative technology aims to reprogram cells at the intracellular level, potentially transforming treatment strategies for conditions like oncology and genetic diseases.
Reference
Core business
Home - Edity Therapeutics
Edity Therapeutics - Cellular Re-programming utilizing the Immune system: We use immune cells to deliver protein directly to the cytoplasm of diseased cells to improve patient health and longevity.
Immunovative Therapies Ltd.
Jerusalem, Israel
B
11-50 Employees
2004
Key takeaway
The company specializes in innovative immunotherapy, particularly focusing on harnessing the body's immune system to combat cancer. Their advanced Mirror Effect® technology platform offers the potential for customized and effective cancer treatments, with their lead product, AlloStim®, entering late-stage clinical development.
Reference
Core business
About Us | mirrorbio
TargetGene Biotechnologies
Rishon LeZion, Israel
B
1-10 Employees
2012
Key takeaway
TargetGene is dedicated to advancing therapeutics through its innovative genome editing platform, which may have implications for developing cutting-edge treatments like CAR-T cell therapy. Their commitment to creating effective therapeutic solutions underscores their focus on bringing cures to patients.
Reference
Core business
TARGETGENE – DEVELOPING THE WORLD’S BEST THERAPEUTIC GENOME EDITING PLATFORM
Looking for more accurate results?
Find the right companies for free by entering your custom query!
25M+ companies
250M+ products
Free to use
Gamida Cell
Jerusalem, Israel
B
101-250 Employees
1998
Key takeaway
Gamida Cell is dedicated to pioneering next-generation cell therapies, including those for cancer, by leveraging their proprietary NAM technology to develop potentially curative treatments. Their focus on cell therapy research and development highlights their commitment to addressing serious medical needs.
Reference
Core business
Gamida Cell - Cell and Immune Therapy Technologies
ADVA Biotechnologies
Haifa, Israel
B
11-50 Employees
2016
Key takeaway
Adva Biotechnology is focused on revolutionizing cell therapy manufacturing through its innovative ADVA platform, which enhances the autologous cell therapy process. Their use of unique CAMP technology suggests a commitment to advancing therapies like CAR-T cell therapy.
Reference
Core business
Home // AdvaBio
VALUING LIFE Granting Advanced Therapies to Patients Automated Autologous Cell Manufacturing Platform Adva Biotechnology introduces the ADVA platform, a fully controlled, flexible, and automated cell processing platform. The system provides a solution to autologous cell therapy manufacturing processes using the unique CAMP (Continues Adaptive Multi-Parameter) technology.
Nanocarry Therapeutics
Nes Ziona, Israel
B
1-10 Employees
2021
Key takeaway
Nanocarry is focused on developing innovative brain therapeutics that combine biological approaches with nanoparticles to enhance the delivery of biologics across the Blood Brain Barrier. Their work aims to create first-in-class treatments for neuro-oncology and central nervous system diseases.
Reference
Core business
Home - Nanocarry
Biologics Beyond Boundaries. Developing first-in-class therapeutics to treat brain cancers and CNS diseases. contact us With a goal to extend the reach of biological therapeutics to the brain to tackle CNS diseases head-on, Nanocarry is pioneering a multidisciplinary approach that enables biologics to access the brain, overcoming the Blood Brain Barrier (BBB). The Challenge Our […]
Stem Cell Medicine
Jerusalem, Israel
B
11-50 Employees
2010
Key takeaway
Stem Cell Medicine is dedicated to developing innovative cell therapy products, particularly focusing on chronic diseases. Their expertise in advanced cell therapies may provide insights into emerging treatments like CAR-T cell therapy.
Reference
Core business
Stem Cell Medicine Ltd.
Kitov Pharmaceuticals
Tel-Aviv, Israel
B
1-10 Employees
2010
Key takeaway
Purple Biotech is focused on developing innovative therapies to combat tumor immune evasion and drug resistance, which is crucial in enhancing the effectiveness of treatments like CAR-T cell therapy. Their pipeline includes first-in-class immune checkpoint inhibitors and novel antibodies that could complement existing cancer therapies.
Reference
Core business
Purple Biotech first-in-class therapies to overcome tumor immune evasion and drug resistance
Purple BioTech - are committed to providing cancer patients with first-in-class, effective, and durable therapies by overcoming tumor immune evasion and drug resistance.
Accellix
Jerusalem, Israel
B
11-50 Employees
2013
Key takeaway
Accellix is focused on enhancing cell therapy through its automated cell phenotyping platform, which integrates flow cytometry into the GMP manufacturing process. This technology allows for real-time measurement of critical quality attributes, ensuring the effective and timely release of CAR-T cell therapy products.
Reference
Core business
Accellix | Benchtop Flow Cytometry for GMP Manufacturing
The Accellix Platform is an easy-to-use benchtop flow cytometer for complex quality control testing throughout the cell therapy manufacturing workflow.
CTX Platforms
Bnei Shimon Regional Council, Israel
B
1-10 Employees
2018
Key takeaway
CTX Platforms Ltd is a biotechnology company focused on innovative cancer treatments. Their technology involves the targeted delivery of magnetic nanoparticles to induce heat and destroy cancer cells, potentially enhancing existing immunotherapy approaches for conditions like GBM.
Reference
Core business
CTX Platforms
Theranostics
Technologies which have been searched by others and may be interesting for you:
When exploring the CAR-T Cell Therapy industry in Israel, several key considerations are essential. Israel boasts a robust biotech ecosystem, characterized by strong research institutions and a high level of innovation. Regulatory frameworks are essential to understand, as the Israeli Ministry of Health oversees the approval processes for new therapies, including CAR-T treatments. Challenges in this field include the complexity of manufacturing CAR-T cells and ensuring consistent quality, which can impact scalability. However, the opportunities are significant, given Israel's advanced technology and expertise in immunotherapy. The competitive landscape features both established companies and startups, making it vital to assess each organization's unique position and innovation capabilities. Collaborations between academia and industry are common, often leading to groundbreaking advancements. Environmental concerns related to biomanufacturing, particularly waste management and resource consumption, are increasingly relevant, prompting companies to adopt sustainable practices. Furthermore, the global market for CAR-T therapies continues to expand, presenting opportunities for Israeli companies to enter international markets. Understanding these dynamics is crucial for anyone looking to engage with or invest in the CAR-T Cell Therapy sector in Israel.
Some interesting numbers and facts about your company results for CAR-T Cell Therapy
| Country with most fitting companies | Israel |
| Amount of fitting manufacturers | 173 |
| Amount of suitable service providers | 58 |
| Average amount of employees | 11-50 |
| Oldest suiting company | 1998 |
| Youngest suiting company | 2021 |
Some interesting questions that has been asked about the results you have just received for CAR-T Cell Therapy
What are related technologies to CAR-T Cell Therapy?
Based on our calculations related technologies to CAR-T Cell Therapy are Biomedical (Red), Bioinformatics (Gold), Environmental Biotechnology (Grey), Agricultural Biotechnology (Green), Food Related Biotechnology (Yellow)
Who are Start-Ups in the field of CAR-T Cell Therapy?
Start-Ups who are working in CAR-T Cell Therapy are Nanocarry Therapeutics
Which industries are mostly working on CAR-T Cell Therapy?
The most represented industries which are working in CAR-T Cell Therapy are Medical, Other, Biotechnology, IT, Software and Services, Pharmaceuticals
How does ensun find these CAR-T Cell Therapy Companies?
ensun uses an advanced search and ranking system capable of sifting through millions of companies and hundreds of millions of products and services to identify suitable matches. This is achieved by leveraging cutting-edge technologies, including Artificial Intelligence.